Month: January 2020

Tepezza (teprotumumab-trbw) Receives FDA Approval

January 21, 2020

(Originally posted January 21, 2020 and March 1, 2019) BREAKING NEWS: The FDA has approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease. Wiley Chambers, M.D., deputy director of the Division of Transplant and Ophthalmology Products in the FDA’s Center for Drug Evaluation and Research noted, “Today’s approval marks an important milestone for…

Read More